80 related articles for article (PubMed ID: 22143356)
1. Characterization of BCL-X L , MCL-1, and BAX Protein Expression in Response to Neoadjuvant Chemotherapy in Breast Cancer.
Saleh T; Al Shboul S; Awad H; El-Sadoni M; Alhesa A; Alsharaiah E; Abu Shahin N; Alotaibi MR; Battah A; Azab B
Appl Immunohistochem Mol Morphol; 2024 Apr; 32(4):189-199. PubMed ID: 38426376
[TBL] [Abstract][Full Text] [Related]
2. A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer.
Ruan T; Liu W; Tao K; Wu C
Onco Targets Ther; 2020; 13():1797-1807. PubMed ID: 32184615
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of p53 Protein Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer.
Baek DW; Kang BW; Hwang S; Kim JG; Seo AN; Bae HI; Kwon OK; Lee SS; Chung HY; Yu W
Chonnam Med J; 2017 May; 53(2):140-146. PubMed ID: 28584793
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of chemoresistance in gastric cancer.
Shi WJ; Gao JB
World J Gastrointest Oncol; 2016 Sep; 8(9):673-81. PubMed ID: 27672425
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of p53 expression in gastric cancer: a meta-analysis.
Wei K; Jiang L; Wei Y; Wang Y; Qian X; Dai Q; Guan Q
J Cancer Res Clin Oncol; 2015 Apr; 141(4):735-48. PubMed ID: 25316440
[TBL] [Abstract][Full Text] [Related]
6. Research and clinical applications of molecular biomarkers in gastrointestinal carcinoma (Review).
Jiao F; Jin Z; Wang L; Wang L
Biomed Rep; 2013 Nov; 1(6):819-827. PubMed ID: 24649035
[TBL] [Abstract][Full Text] [Related]
7. Human epidermal growth factor receptor 2 (Her-2) and S-1 adjuvant chemotherapy in stage 2/3 gastric cancer patients who underwent D2 gastrectomy.
Aoyama T; Yoshikawa T; Miyagi Y; Kameda Y; Shirai J; Hayashi T; Cho H; Oshima T; Yukawa N; Rino Y; Masuda M; Tsuburaya A
Surg Today; 2013 Dec; 43(12):1390-7. PubMed ID: 23512532
[TBL] [Abstract][Full Text] [Related]
8. UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (carcinoma of the lung, stomach, colon/rectum, and breast): clinical evidence, mechanism of action, and future direction.
Tanaka F
Surg Today; 2007; 37(11):923-43. PubMed ID: 17952521
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non-small cell lung cancer.
Tanaka F; Yanagihara K; Otake Y; Miyahara R; Wada H
Cancer Sci; 2004 Apr; 95(4):371-6. PubMed ID: 15072598
[TBL] [Abstract][Full Text] [Related]
10. Relationship between expression of apoptosis-related proteins and the efficacy of postoperative chemotherapy in patients with T3 gastric cancer.
Tsujitani S; Saito H; Wakatsuki T; Ikeguchi M; Shirabe K; Morita M; Kakeji Y; Yano T; Maehara Y
Surg Today; 2012 Feb; 42(3):225-32. PubMed ID: 22143356
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group.
Nakajima T; Nashimoto A; Kitamura M; Kito T; Iwanaga T; Okabayashi K; Goto M
Lancet; 1999 Jul; 354(9175):273-7. PubMed ID: 10440302
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant tegafur-uracil (UFT) or S-1 monotherapy for advanced gastric cancer: a single center experience.
Yen HH; Chen CN; Yeh CC; Lai IR
World J Surg Oncol; 2021 Apr; 19(1):124. PubMed ID: 33865416
[TBL] [Abstract][Full Text] [Related]
13. Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery.
Okuyama T; Korenaga D; Edagawa A; Itoh S; Oki E; Kawanaka H; Ikeda Y; Kakeji Y; Tateishi M; Tsujitani S; Takenaka K; Maehara Y
Surg Today; 2012 Aug; 42(8):734-40. PubMed ID: 22278622
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
